Cinctive Capital Management LP Makes New Investment in Alignment Healthcare, Inc. $ALHC
Cinctive Capital Management LP purchased a new stake in shares of Alignment Healthcare, Inc. (NASDAQ: ALHC) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 218,589 shares of the company's stock, valued at approximately $3,814,000. Cinctive Capital Management LP owned approximately
8 Knots Management LLC Sells 2,122,788 Shares of Alignment Healthcare, Inc. $ALHC
8 Knots Management LLC lowered its holdings in Alignment Healthcare, Inc. (NASDAQ: ALHC) by 42.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,893,093 shares of the company's stock after selling 2,122,788 shares during the quarter. Alignment
Alignment Healthcare, Inc. $ALHC Position Decreased by General Atlantic L.P.
General Atlantic L.P. decreased its holdings in shares of Alignment Healthcare, Inc. (NASDAQ: ALHC) by 44.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 24,287,227 shares of the company's stock after selling 19,706,096 shares during the period.
Alignment Healthcare, Inc. (ALHC) Q4 2025 Earnings Call Transcript
Alignment Healthcare, Inc. (ALHC) Q4 2025 Earnings Call Transcript
Alignment Healthcare (ALHC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Alignment Healthcare (ALHC) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Alignment Healthcare (ALHC) Reports Q4 Loss, Beats Revenue Estimates
Alignment Healthcare (ALHC) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.16 per share a year ago.
U.S. Managed Care Insurers To Post Lower Q4 2025 Net Income Amid Higher Costs
U.S. Managed Care Insurers To Post Lower Q4 2025 Net Income Amid Higher Costs
ALHC Stock Surges 400%—Here's Why the Bulls Aren't Done
Alignment Healthcare Inc. (NASDAQ: ALHC) is an example of why even buy-and-hold investors need to leave room for nimble movement. ALHC stock is up more than 58% in the last 12 months and more than 415% since April 2024.
Alignment Healthcare, Inc. (ALHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Alignment Healthcare, Inc. (ALHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Alignment Healthcare, Inc. (ALHC) Q3 2025 Earnings Call Transcript
Alignment Healthcare, Inc. ( ALHC ) Q3 2025 Earnings Call October 30, 2025 5:00 PM EDT Company Participants John Kao - Founder, CEO & Director James Head - Chief Financial Officer Conference Call Participants Scott Fidel - Goldman Sachs Group, Inc., Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Michael Ha Jessica Tassan - Piper Sandler & Co., Research Division Ryan Langston - TD Cowen, Research Division Craig Jones - BofA Securities, Research Division Andrew Mok - Barclays Bank PLC, Research Division Benjamin Mayo - Leerink Partners LLC, Research Division Jonathan Yong Ryan Daniels - William Blair & Company L.L.C., Research Division Presentation Operator Good afternoon, and welcome to Alignment Healthcare's Third Quarter 2025 Earnings Conference Call and Webcast.
Alignment Healthcare (ALHC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Alignment Healthcare (ALHC) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Alignment Healthcare (ALHC) Q3 Earnings and Revenues Beat Estimates
Alignment Healthcare (ALHC) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to a loss of $0.14 per share a year ago.
